[Retracted] Application Effect of Somatostatin Combined with Transnasal Ileus Catheterization in Patients with Acute Intestinal Obstruction and Advanced Gastric Cancer

Table 2

Comparison of serum-related indicators ( ± S).

Group	Time	Control group (n = 47)	Study group (n = 47)
CRP (mg/L)	Before the treatment	35.61 ± 7.38	35.62 ± 7.40
	After the treatment	24.69 ± 5.64	14.35 ± 4.32
IgA (g/L)	Before the treatment	2.19 ± 0.51	2.16 ± 0.52
	After the treatment	1.82 ± 0.45	1.54 ± 0.36
LPS (μmol/L)	Before the treatment	193.62 ± 24.69	192.84 ± 24.70
	After the treatment	84.59 ± 17.72	41.38 ± 12.34
FABP (ng/L)	Before the treatment	275.64 ± 22.56	274.95 ± 23.14
	After the treatment	225.86 ± 19.67	175.68 ± 16.35

Note, compared with control group, .